Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
631 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-21 |
Cash Flow (TTM) (Millions $) |
4 |
Capital Exp. (TTM) (Millions $) |
1 |
Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. is a biotechnology company specializing in the research, development, and commercialization of innovative diagnostics and therapeutics. The company focuses on the fields of neurology, psychiatry, and ophthalmology. They aim to provide solutions for diseases with significant unmet medical needs, such as Alzheimer's disease, Parkinson's disease, and traumatic brain injuries. Amarantus Bioscience Holdings also owns subsidiaries and licenses technologies with the potential for groundbreaking advancements in the healthcare industry.
|